---
layout: splash
title: 차바이오텍 (085660)
excerpt: 차바이오텍의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 차바이오텍, 085660
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 17,030 | <span style="color: cornflowerblue">-0.5<small>%</small></span> | Q:제약 | - | 3.4 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 세포치료제 개발, 제대혈 보관 등 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2005년 12월 27일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 오상훈 (단독대표) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.chabio.com](http://www.chabio.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 06&#x2011;05 | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240605000402){:target="_blank"} |
| 06&#x2011;03 | | [기업설명회(IR)개최              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240603900092){:target="_blank"} |
| 05&#x2011;31 | | [대표이사변경              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240531900337){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![085660](/stock/images/085660.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 17,030 | <span style="color: cornflowerblue">-0.5<small>%</small></span> | <span style="color: tomato">2.5<small>%</small></span> | <span style="color: cornflowerblue">-2.1<small>%</small></span> | <span style="color: cornflowerblue">-10.7<small>%</small></span> | <span style="color: tomato">9.6<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">10.6<small>%</small></span> | 46.7<small>%</small> | 0.23 | -30.9<small>%</small> | -17.7<small>%</small> | -0.3 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 3.4 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/085660/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=085660){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A085660&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=085660){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/085660){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/085660/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![085660](/stock/images/085660_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 10.6<small>%</small> | 46.7<small>%</small> | 0.23 | -30.9<small>%</small> | -17.7<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 3.2<small>%</small> | 46.1<small>%</small> | 0.07 | -36.3<small>%</small> | -21.5<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -10.9<small>%</small> | 29.5<small>%</small> | -0.37 | -30.1<small>%</small> | -15.0<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 34.0<small>%</small> | 37.3<small>%</small> | 0.91 | -18.6<small>%</small> | -7.1<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 9.6<small>%</small> | 38.6<small>%</small> | 0.25 | -31.2<small>%</small> | -17.4<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -10.4<small>%</small> | 38.1<small>%</small> | -0.27 | -37.2<small>%</small> | -23.3<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -7.7<small>%</small> | 41.7<small>%</small> | -0.18 | -36.8<small>%</small> | -21.3<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 2.5<small>%</small> | 44.1<small>%</small> | 0.06 | -30.9<small>%</small> | -17.4<small>%</small> |
| MACD[^fn_tech_metric_macd] | 14.5<small>%</small> | 40.4<small>%</small> | 0.36 | -29.0<small>%</small> | -14.9<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![085660](/stock/images/085660_corr.png){: .align-center}

|       | [레인보우로보틱스](/277810/) | [대웅](/003090/) | [세방전지](/004490/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [대웅제약](/069620/) | [삼천당제약](/000250/) | [신한지주](/055550/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![085660](/stock/images/085660_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}